Cargando…

Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters

OBJECTIVE: Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cafaro, Giacomo, Bartoloni, Elena, Baldini, Chiara, Franceschini, Franco, Riccieri, Valeria, Fioravanti, Antonella, Fornaro, Marco, Ghirardello, Anna, Palterer, Boaz, Infantino, Maria, Rigon, Amelia, Del Rosso, Stefania, Gerli, Roberto, Villalta, Danilo, Bizzaro, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Connective Tissue Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514657/ https://www.ncbi.nlm.nih.gov/pubmed/37734871 http://dx.doi.org/10.1136/rmdopen-2023-003365

Ejemplares similares

Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases
por: Bizzaro, Nicola, et al.
Publicado: (2022)

Anti-SMN autoantibodies in mixed connective tissue disease are associated with a severe systemic sclerosis phenotype
por: El Kamouni, Hajar, et al.
Publicado: (2023)

Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases
por: Zarbl, Joshua, et al.
Publicado: (2022)

Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging
por: Hysa, Elvis, et al.
Publicado: (2023)

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines
por: Antunes, Margarida, et al.
Publicado: (2019)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

Mixed connective tissue disease: state of the art on clinical practice guidelines
por: Chaigne, Benjamin, et al.
Publicado: (2018)

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
por: Seror, Raphaèle, et al.
Publicado: (2015)

IgG4-related diseases: state of the art on clinical practice guidelines
por: Iaccarino, Luca, et al.
Publicado: (2019)

Comparison between primary Sjögren’s disease patients with high or low level of dryness
por: Kachaner, Alexandra, et al.
Publicado: (2023)

Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
por: Cannizzo, Sara, et al.
Publicado: (2018)

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?
por: Panagiotopoulos, Alexandros, et al.
Publicado: (2023)

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021)

Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
por: Ritschl, Valentin, et al.
Publicado: (2021)

Neutrophil extracellular traps (NET): not only antimicrobial but also modulators of innate and adaptive immunities in inflammatory autoimmune diseases
por: Melbouci, Dyhia, et al.
Publicado: (2023)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

Exploring patient’s experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach
por: Marinello, Diana, et al.
Publicado: (2022)

Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET)
por: Mosca, Marta, et al.
Publicado: (2018)

Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey
por: Talarico, Rosaria, et al.
Publicado: (2020)

Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study
por: Abe, Kazuya, et al.
Publicado: (2023)

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2016)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
por: Bottai, Matteo, et al.
Publicado: (2017)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
por: van den Hoogen, Lucas L, et al.
Publicado: (2018)

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
por: Ide, Veerle, et al.
Publicado: (2018)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
por: Chen, Bo, et al.
Publicado: (2019)

Distinct interferon signatures stratify inflammatory and dysimmune myopathies
por: Rigolet, Muriel, et al.
Publicado: (2019)

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
por: Meyer, Alain, et al.
Publicado: (2019)

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines
por: Sulli, Alberto, et al.
Publicado: (2018)

Relapsing polychondritis: state of the art on clinical practice guidelines
por: Rednic, Simona, et al.
Publicado: (2018)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
por: Howard Tripp, Nadia, et al.
Publicado: (2016)

MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
por: Ukichi, Taro, et al.
Publicado: (2019)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study
por: Abisror, Noemie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62ao9iv992p6ghd4l3qsrf8ljk